Image_2_A Two-Gene-Based Diagnostic Signature for Ruptured Intracranial Aneurysms.TIF by Yuwang Li (11270949)

Image_1_A Two-Gene-Based Diagnostic Signature for Ruptured Intracranial Aneurysms.JPEG by Yuwang Li (11270949)

Effects of SB-431542 in bladder smooth muscle cell differentiation: A) Top left panel. by Syed S. Islam (404861)

Image_3_A Two-Gene-Based Diagnostic Signature for Ruptured Intracranial Aneurysms.TIF by Yuwang Li (11270949)

Methylation Microarray Studies Highlight <i>PDGFA</i> Expression as a Factor in Biliary Atresia by Zenobia C. Cofer (2580166)

Phonation threshold pressure & laryngeal scarring (Ramanathan et al., 2022) by Pradeep Ramanathan (13983760)

Adipose tissue depot volume relationships with spinal trabecular bone mineral density in African Americans with diabetes by Gary C. Chan (4794924)

“…Over 5.3 ± 1.4 years, mean vBMD decreased in thoracic/lumbar spine, while mean adipose tissue volumes increased in SAT, IMAT, and PAT, but not VAT depots. …”

Brittle Culm1, a COBRA-Like Protein, Functions in Cellulose Assembly through Binding Cellulose Microfibrils by Lifeng Liu (164546)

Image_1_Genome-Wide Identification of a Regulatory Mutation in BMP15 Controlling Prolificacy in Sheep.TIFF by Louise Chantepie (8994092)

“…At the molecular level, FecX^N was shown to decrease BMP15 promoter activity and supposed to impact BMP15 expression in the oocyte. …”

Table_1_Genome-Wide Identification of a Regulatory Mutation in BMP15 Controlling Prolificacy in Sheep.DOCX by Louise Chantepie (8994092)

“…At the molecular level, FecX^N was shown to decrease BMP15 promoter activity and supposed to impact BMP15 expression in the oocyte. …”

Table_2_Genome-Wide Identification of a Regulatory Mutation in BMP15 Controlling Prolificacy in Sheep.DOCX by Louise Chantepie (8994092)

“…At the molecular level, FecX^N was shown to decrease BMP15 promoter activity and supposed to impact BMP15 expression in the oocyte. …”

Size variation of δ¹⁵N in <i>Mytilus galloprovincialis.</i> by Antonio Bode (1473376)

FPR1/2/3 expression changes of blood immune cells after 6-month CPAP treatment. by Yung-Che Chen (381913)

“…<p>(A) FPR1 (+) percentage on neutrophil was decreased after > 6-month CPAP treatment. …”

A systematic review of consumer preference for e-cigarette attributes: Flavor, nicotine strength, and type by Samane Zare (4966786)

Results of the DSA for the number of referrals to TVS. by Benjamin Ruban-Fell (10791208)

Analyses of directed phase lag index (dPLI [44]) for excitatory/inhibitory (E/I) ratios with respect to pyramidal (Pyr) and parvalbumin (PV) populations (<i>A</i>) and Pyr and soma... by Nobuhiko Wagatsuma (494052)

“…<p>Black circles and gray pentagons represent the mean values of dPLI from PV to Pyr and from SOM to Pyr populations, respectively. …”

Results of the DSA for the number of diagnosed VP cases. by Benjamin Ruban-Fell (10791208)

Docking results of effective compounds in TFDM. by Xu Hu (23350)

“…</p><p>Results</p><p>21 active components were screened, 158 potential drug targets for the prevention and treatment of CIRI were obtained, 53 main targets were further screened in the protein-protein interaction network, and 106 signal pathways, 76 biological processes, 26 cell components and 50 molecular functions were enriched (P<0.05). Through the compound-target-pathway network, the key compounds that play a role in the prevention and treatment of CIRI, such as acacetin, apigenin and other flavonoids, as well as the corresponding key targets and key signal pathways, such as AKT1, SRC and EGFR were obtained. …”

Active compounds screened from TFDM. by Xu Hu (23350)

“…</p><p>Results</p><p>21 active components were screened, 158 potential drug targets for the prevention and treatment of CIRI were obtained, 53 main targets were further screened in the protein-protein interaction network, and 106 signal pathways, 76 biological processes, 26 cell components and 50 molecular functions were enriched (P<0.05). Through the compound-target-pathway network, the key compounds that play a role in the prevention and treatment of CIRI, such as acacetin, apigenin and other flavonoids, as well as the corresponding key targets and key signal pathways, such as AKT1, SRC and EGFR were obtained. …”

Network of compound-target-pathway. by Xu Hu (23350)

“…</p><p>Results</p><p>21 active components were screened, 158 potential drug targets for the prevention and treatment of CIRI were obtained, 53 main targets were further screened in the protein-protein interaction network, and 106 signal pathways, 76 biological processes, 26 cell components and 50 molecular functions were enriched (P<0.05). Through the compound-target-pathway network, the key compounds that play a role in the prevention and treatment of CIRI, such as acacetin, apigenin and other flavonoids, as well as the corresponding key targets and key signal pathways, such as AKT1, SRC and EGFR were obtained. …”